Hutchison MediPharma Founder And CEO Samantha Du On China's Drug R&D Ecosystem: An Interview With PharmAsia News

Among the first wave of returnees back to China, Samantha Du, who conducted global licensing for metabolic diseases with Pfizer, and cofounded Hutchison Chi-Med., returned to Shanghai to start biotech company Hutchison MediPharma in 2002